GENMAB A/SGMAB财报
Nasdaq · 医疗保健 · 药物制剂
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab (Suzhou) Co., Ltd. in Suzhou, China. Genmab is listed on the Co...
What changed in GENMAB A/S's 6-K — 2024 vs 2025
No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.